Log In
BCIQ
Print this Print this
 

BB3

  Manage Alerts
Collapse Summary General Information
Company Angion Biomedica Corp.
DescriptionSmall molecule with hepatocyte growth factor (HGF)-like activities
Molecular Target c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene)
Mechanism of Actionc-Met receptor tyrosine kinase agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/16/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today